Medications for the treatment of obesity.

Carette, C; Rives-Lange, C; Czernichow, S

Carette, C; Rives-Lange, C; Czernichow, S.

Affiliation

Carette C; Paris Cité University, Nutrition Department, Specialized Obesity Center, Georges Pompidou European Hospital, AP-HP, 20, rue Leblanc, Paris, France.
Rives-Lange C; Paris Cité University, Nutrition Department, Specialized Obesity Center, Georges Pompidou European Hospital, AP-HP, 20, rue Leblanc, Paris, France.
Czernichow S; Paris Cité University, Nutrition Department, Specialized Obesity Center, Georges Pompidou European Hospital, AP-HP, 20, rue Leblanc, Paris, France. Electronic address: sebastien.czernichow@aphp.fr.

J Visc Surg ; 160(2S): S12-S14, 2023 04.

Article in En | MEDLINE | ID: mdl-36725455

Subject(s)

Leptin; Obesity; Humans; Leptin/metabolism; Leptin/pharmacology; Obesity/drug therapy; Hypothalamus/metabolism

Key words

GLP1 receptor agonists; Glucagon intestinal peptide (GIP); Hypothalamus; Leptin-melanocortin Leptin; Suspensive pharmacotherapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leptin / Obesity Type of study: Risk_factors_studies Limits: Humans Language: En Journal: J Visc Surg Journal subject: GASTROENTEROLOGIA Year: 2023 Document type: Article Affiliation country: France Country of publication: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google